drugset / Trial / NCT06434961
The Trial of SHR6508 in Secondary Hyperparathyroidism
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is being conducted to evaluate the efficacy and safety of SHR6508 among Chinese patients with secondary hyperparathyroidism of chronic kidney disease treated by maintenance hemodialysis.
Timeline
- Start
- 2024-06-14
- Primary completion
- 2025-09-29
- Completion
- 2025-11-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cinacalcet | Other / unclassified | — | — |
| Subject | SHR6508 | Unknown | — | — |